Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
CDC’s Division of Viral Hepatitis is leading a national campaign called Know More Hepatitis.
Like the HIV/AIDS epidemic nearly 40 years ago, the coronavirus pandemic may prove particularly lethal to incarcerated people.
A survey of local health departments reveals concerning news—and a silver lining.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
The nonprofit represents health officials who oversee HIV and hepatitis programs in the United States and across the globe.
Health officials with Goshen Hospital in Indiana called the risk of infection “extremely low.”
Events are scheduled throughout September to raise awareness about hep B and HIV in these communities.
Researchers followed people with a drug-injection history who had been cured of hepatitis C and were receiving addiction treatment.
National survey finds HBV rate is four times higher than that of the overall U.S. population.
A new study appears to resolve controversy over hep C treatment’s association with mortality risk.
What do you know about hepatitis E?
An outbreak has prompted a mass vaccination effort.
Better treatments for hepatitis B and C and a lack of such advances for fatty liver or alcoholic liver disease are driving outcomes.
This is one of several lawsuits filed by advocates on behalf of inmates with the liver virus in U.S. prisons.
Four things you should know to be #HepAware.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.